Quest Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$539K Sell
22,370
-8,025
-26% -$210K 0.06% 91
2026
Q1
$853K Sell
30,395
-892
-3% -$23.7K 0.1% 83
2025
Q4
$779K Sell
31,287
-481
-2% -$12.1K 0.08% 86
2025
Q3
$809K Buy
31,768
+405
+1% +$10K 0.09% 88
2025
Q2
$760K Buy
+31,363
New +$731K 0.08% 88

Other funds holding PFE

Quest Investment Management's PFE Position: Q2 2026 in Review

Quest Investment Management reduced its Pfizer (PFE) stake by 26% in Q2 2026, selling an estimated $210K and leaving 22,370 shares worth $539K. The position accounts for 0.06% of the portfolio, ranked #91.

Quest Investment Management first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $853K in Q1 2026. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Quest Investment Management held 22,370 shares of Pfizer worth $539K as of Q2 2026.
  • Quest Investment Management sold 8,025 Pfizer shares in Q2 2026, an estimated $210K.
  • Pfizer made up 0.06% of Quest Investment Management's portfolio in Q2 2026, its #91 holding.
  • Quest Investment Management first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
  • Quest Investment Management's Pfizer position peaked at $853K in Q1 2026.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Quest Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.